Interdisciplinary approach to treat dyskeratosis congenita associated with severe aplastic anemia: A case report

Special Care in Dentistry

Volumn 26, Issue 2, 2006, Pages 81-84

  Gomes, Mônica Fernandes ^a,b   De Abreu, Paula Pinheiro ^a   Banzi, Éfani Caroline De Freitas ^a   Nogueira, Terezinha De Oliveira ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Depto Biociencias Diagnostico Oral   (Brazil)

Author keywords

Aplastic anemia; Congenita; Dyskeratosis; Interdisciplinary team; Oral manifestations; Special care

Indexed keywords

EID: 33744805767     PISSN: 02751879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1754-4505.2006.tb01515.x     Document Type: Article

References (19)

1. Inoue S, Mekanik G, Mahallati M, Zuelzer WW. Dyskeratosis congenita with pancytopenia. Another constitutional anemia. Am J Dis Child 1973;126:389-96.
2. Yavuzyilmaz E, Yamalik N, Yetgin S, Kansu O. Oral-dental findings in dyskeratosis congenita. J Oral Pathol Med 1992;21:280-4.
3. Brown CJ. Dyskeratosis congenita: report of a case. Int J Paediatr Dent 2000;10:528-34.
4. Bagby GC, Lipton JM, Sloand EM, Schiffer CA. Marrow failure. Hematology 2004;318-36.
5. Treister N, Lehmann EE, Cherrick I, Guinan EC, Woo SB. Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:566-71.
6. De Boeck K, Degreef H, Verwilghen R, Corbeel L, Casteels-Van Daele M. Trombocytopenia: first symptom in a patient with dyskeratosis congenita. Pediatrics 1981;67:898-903.
7. Heiss NS, Girod A, Salowsky R, Wiemann S, Pepperkok R, Poustka A. Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita. Hum Mol Genet 1999;8:2515-24.
8. Bessler M, Wilson DB, Mason PJ. Dyskeratosis congenita and telomerase. Clin Opin Pediatr 2004;16:23-8.
9. Marrone A, Dokal I. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Expert Rev Mol Med 2004;6:1-23.
10. Yamaguchi H, Baerlocher GM, Lansdorp PM. et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 2003;102:916-8.
11. Marsh CW, Testa NG. Stem cell defect in aplastic anemia. In: Aplastic Anemia: Pathophysiology and Treatment. Scherezenmeier H, Bacigalupo A, editors. Cambridge, UK: Cambridge University Press, pp. 3-20, 2000.
12. Gibson FM, Philpott NJ, Marsh JCW, et al. Role of apoptosis in the pathophysiology of aplastic anemia. In: Aplastic Anemia: Pathophysiology and Treatment. Scherezenmeier H, Bacigalupo A, editors. Cambridge, UK: Cambridge University Press, pp. 58-69, 2000.
13. Myer SA, Oliva J. Severe aplastic anemia and allogeneic hematopoietic stem cell transplantation. AACN Clin Issues 2002;13:169-91.
14. Huang H, Yu W, Huang Y, Hwang W, Tsao C, Liu H, Huang G. Aplastic anemia associated with dyskeratosis congenita treated with antilymphocyte globulin and cyclosporine: a case report. Chin Med J 2005;118(9):790-2.
15. Wald C, Diner H. Dyskeratosis congenita with associated periodontal disease. Oral Surg Oral Med Oral Pathol 1974;37:736-44.
16. Utz JP, Ryu, JH, Myers JL, Michels VV. Usual interstitial pneumonia complicating dyskeratosis congenita. Mayo Clin Proc 2005;80(6):817-21.
17. Sawant P, Chopda NM, Desai DC, Dave UR, Satarkar RP, Nanivadekar SA. Dyskeratosis congenita with esophageal stricture and dermatological manifestations. Endoscopy 1994;26:711-2.
18. Limmer RL, Zurowski SM, Swinfard RW. Abnormal nails in a patient with severe anemia. Dyskeratosis congenita. Arch Dermatol 1997;133(1):97-8, 101.
19. Anil S, Beena VT, Raji MA, Remani P, Ankathil R, Vijayakumar T. Oral squamous cell carcinoma in case of Dyskeratosis Congenita. Ann Dent 1994;53(1):15-8.